Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Moiseev

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Kardiologiia|September 28, 2011
[Consensus of experts on the role of ethyl esters of omega-3 polyunsaturated fatty acids for the treatment and prevention of chronic heart failure (conclusion of experts meeting, June 2011)]Iu N Belenkov, V Iu Mareev, G P Arutiunov, et al.
Terapevticheskii Arkhiv|July 4, 2013
[Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases]S V Moiseev, P I Novikov, E N Semenkova, et al.
Terapevticheskii Arkhiv|March 15, 2021
[Risk factors for the early development of septic shock in patients with severe COVID-19]P V Glybochko, V V Fomin, S V Moiseev, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Kardiologiia|September 28, 2011
[Consensus of experts on the role of ethyl esters of omega-3 polyunsaturated fatty acids for the treatment and prevention of chronic heart failure (conclusion of experts meeting, June 2011)]Iu N Belenkov, V Iu Mareev, G P Arutiunov, et al.
Terapevticheskii Arkhiv|July 4, 2013
[Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases]S V Moiseev, P I Novikov, E N Semenkova, et al.
Terapevticheskii Arkhiv|March 15, 2021
[Risk factors for the early development of septic shock in patients with severe COVID-19]P V Glybochko, V V Fomin, S V Moiseev, et al.
Pageof 12